CANQF — CanaQuest Medical Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.30m
- $0.41m
Annual income statement for CanaQuest Medical, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2014 March 31st | 2015 March 31st | 2016 March 31st | 2017 March 31st | 2018 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Cost of Revenue | |||||
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 0.233 | 1.09 | 1.92 | 2.59 | 1.1 |
Operating Profit | -0.233 | -1.09 | -1.92 | -2.59 | -1.1 |
Net Income Before Taxes | -0.233 | -1.09 | -1.92 | -2.59 | -1.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.233 | -1.09 | -1.91 | -2.59 | -1.1 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.233 | -1.09 | -1.91 | -2.59 | -1.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.233 | -1.09 | -1.91 | -2.59 | -1.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.025 | -0.118 | -0.199 | -0.18 | -0.077 |
Dividends per Share |